These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 33851387)

  • 21. Platelet miRNA-26b down-regulates multidrug resistance protein 4 in patients on chronic aspirin treatment.
    La Rosa G; Biasucci LM; Mandolini C; Massimi I; Copponi G; Pulcinelli FM; Crea F
    J Cardiovasc Med (Hagerstown); 2018 Oct; 19(10):611-613. PubMed ID: 30015780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The ABCC4 membrane transporter modulates platelet aggregation.
    Cheepala SB; Pitre A; Fukuda Y; Takenaka K; Zhang Y; Wang Y; Frase S; Pestina T; Gartner TK; Jackson C; Schuetz JD
    Blood; 2015 Nov; 126(20):2307-19. PubMed ID: 26405223
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Several adaptor proteins promote intracellular localisation of the transporter MRP4/ABCC4 in platelets and haematopoietic cells.
    Schaletzki Y; Kromrey ML; Bröderdorf S; Hammer E; Grube M; Hagen P; Sucic S; Freissmuth M; Völker U; Greinacher A; Rauch BH; Kroemer HK; Jedlitschky G
    Thromb Haemost; 2017 Jan; 117(1):105-115. PubMed ID: 27761583
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRP4/ABCC4 expression is regulated by histamine in acute myeloid leukemia cells, determining cAMP efflux.
    Rodríguez González A; Sahores A; Díaz-Nebreda A; Yaneff A; Di Siervi N; Gómez N; Monczor F; Fernández N; Davio C; Shayo C
    FEBS J; 2021 Jan; 288(1):229-243. PubMed ID: 32333821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multidrug Resistance Protein 4 (MRP4/ABCC4): A Suspected Efflux Transporter for Human's Platelet Activation.
    Angelis I; Moussis V; Tsoukatos DC; Tsikaris V
    Protein Pept Lett; 2021; 28(9):983-995. PubMed ID: 33964863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRP4 over-expression has a role on both reducing nitric oxide-dependent antiplatelet effect and enhancing ADP induced platelet activation.
    Guarino ML; Massimi I; Alemanno L; Conti L; Angiolillo DJ; Pulcinelli FM
    J Thromb Thrombolysis; 2021 Apr; 51(3):625-632. PubMed ID: 32803738
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multidrug resistance protein 4 (MRP4/ABCC4) regulates thrombus formation in vitro and in vivo.
    Lien LM; Chen ZC; Chung CL; Yen TL; Chiu HC; Chou DS; Huang SY; Sheu JR; Lu WJ; Lin KH
    Eur J Pharmacol; 2014 Aug; 737():159-67. PubMed ID: 24836986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
    Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The MRP4/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP.
    van Aubel RAMH; Smeets PHE; Peters JGP; Bindels RJM; Russel FGM
    J Am Soc Nephrol; 2002 Mar; 13(3):595-603. PubMed ID: 11856762
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. cAMP regulates expression of the cyclic nucleotide transporter MRP4 (ABCC4) through the EPAC pathway.
    Bröderdorf S; Zang S; Schaletzki Y; Grube M; Kroemer HK; Jedlitschky G
    Pharmacogenet Genomics; 2014 Oct; 24(10):522-6. PubMed ID: 25121519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The nucleotide transporter MRP4 (ABCC4) is highly expressed in human platelets and present in dense granules, indicating a role in mediator storage.
    Jedlitschky G; Tirschmann K; Lubenow LE; Nieuwenhuis HK; Akkerman JW; Greinacher A; Kroemer HK
    Blood; 2004 Dec; 104(12):3603-10. PubMed ID: 15297306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells.
    Eigenthaler M; Nolte C; Halbrügge M; Walter U
    Eur J Biochem; 1992 Apr; 205(2):471-81. PubMed ID: 1315268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Octimibate inhibition of platelet aggregation: stimulation of adenylate cyclase through prostacyclin receptor activation.
    Seiler S; Brassard CL; Arnold AJ; Meanwell NA; Fleming JS; Keely SL
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1021-6. PubMed ID: 2175792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Platelet prostaglandin E1 hyposensitivity in schizophrenia: reduction of prostaglandin E1- or forskolin-stimulated cyclic AMP response in platelets.
    Ofuji M; Kaiya H; Nozaki M; Tsurumi K
    Life Sci; 1989; 45(22):2135-40. PubMed ID: 2557518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MRP4 and CFTR in the regulation of cAMP and β-adrenergic contraction in cardiac myocytes.
    Sellers ZM; Naren AP; Xiang Y; Best PM
    Eur J Pharmacol; 2012 Apr; 681(1-3):80-7. PubMed ID: 22381067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aspirin extrusion from human platelets through multidrug resistance protein-4-mediated transport: evidence of a reduced drug action in patients after coronary artery bypass grafting.
    Mattiello T; Guerriero R; Lotti LV; Trifirò E; Felli MP; Barbarulo A; Pucci B; Gazzaniga P; Gaudio C; Frati L; Pulcinelli FM
    J Am Coll Cardiol; 2011 Aug; 58(7):752-61. PubMed ID: 21816313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production of phosphatidylinositol 3,4,5-trisphosphate and phosphatidic acid in platelet rafts: evidence for a critical role of cholesterol-enriched domains in human platelet activation.
    Bodin S; Giuriato S; Ragab J; Humbel BM; Viala C; Vieu C; Chap H; Payrastre B
    Biochemistry; 2001 Dec; 40(50):15290-9. PubMed ID: 11735411
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.